Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report

Vadood Javadi Parvaneh, Mohsen Jari, Saeideh Qhasemi, Mohammad Mahdi Nasehi, Khosro Rahmani, Reza ShiariMofid Children’s Hospital, Shahid Beheshti Medical University of Sciences, Tehran, IranBackground: Systemic lupus erythematosus (SLE) is an autoimmune disease which involves multiple org...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Javadi Parvaneh V, Jari M, Qhasemi S, Nasehi MM, Rahmani K, Shiari R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/2596f2d1d2c047a0aa3f6f7296aab88a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2596f2d1d2c047a0aa3f6f7296aab88a
record_format dspace
spelling oai:doaj.org-article:2596f2d1d2c047a0aa3f6f7296aab88a2021-12-02T03:25:53ZGuillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report1179-156Xhttps://doaj.org/article/2596f2d1d2c047a0aa3f6f7296aab88a2019-04-01T00:00:00Zhttps://www.dovepress.com/guillain-barre-syndrome-as-the-first-manifestation-of-juvenile-systemi-peer-reviewed-article-OARRRhttps://doaj.org/toc/1179-156XVadood Javadi Parvaneh, Mohsen Jari, Saeideh Qhasemi, Mohammad Mahdi Nasehi, Khosro Rahmani, Reza ShiariMofid Children’s Hospital, Shahid Beheshti Medical University of Sciences, Tehran, IranBackground: Systemic lupus erythematosus (SLE) is an autoimmune disease which involves multiple organs, including peripheral nervous system.Case presentation: We describe a 12-year-old boy with progressively worsening neurological symptoms as first manifestation. Legs pain, loss of balance, and lower extremity weakness were the reason for his admission in neurologic ward. The patient was started on intravenous immunoglobulin therapy due to the possibility of Guillain–Barre syndrome and acute inflammatory demyelinating polyneuropathy (AIDP). However, there was no appropriate response and he developed recurrent attacks of polyneuropathy again with diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Then, he received intravenous pulse of methylprednisolone for 5 consecutive days followed by oral prednisolone for 3 months. One month after withdrawal of corticosteroid he admitted again with the same manifestations. Rheumatologic workup revealed the presence of leukopenia, hemolytic anemia, hematuria, proteinuria, positive antinuclear antibodies, and ds-DNA antibodies. On the basis of the American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria for SLE, the patient had underlying diagnosis of SLE. Eventually, he was treated by the pulse of methylprednisolone and cyclophosphamide, and oral hydroxychloroquine and prednisolone. His neurological and physical symptoms improved and complete neurological recovery occurred several months later.Conclusion: SLE and AIDP/CIDP are different entities, but ADP/CIDP can be part of the neurologic manifestations of the SLE. Although the association between AIDP/CIDP and SLE is very rare especially as a first manifestation of SLE, it should be early recognized for rapid appropriate treatment.Keywords: Guillain–Barre syndrome, chronic inflammatory demyelinating polyneuropathy, systemic lupus erythematosus, nerve disordersJavadi Parvaneh VJari MQhasemi SNasehi MMRahmani KShiari RDove Medical PressarticleGuillain-Barre syndromechronic inflammatory demyelinating polyneuropathysystemic lupus erythematosusnerve disordersDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 11, Pp 97-101 (2019)
institution DOAJ
collection DOAJ
language EN
topic Guillain-Barre syndrome
chronic inflammatory demyelinating polyneuropathy
systemic lupus erythematosus
nerve disorders
Diseases of the musculoskeletal system
RC925-935
spellingShingle Guillain-Barre syndrome
chronic inflammatory demyelinating polyneuropathy
systemic lupus erythematosus
nerve disorders
Diseases of the musculoskeletal system
RC925-935
Javadi Parvaneh V
Jari M
Qhasemi S
Nasehi MM
Rahmani K
Shiari R
Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
description Vadood Javadi Parvaneh, Mohsen Jari, Saeideh Qhasemi, Mohammad Mahdi Nasehi, Khosro Rahmani, Reza ShiariMofid Children’s Hospital, Shahid Beheshti Medical University of Sciences, Tehran, IranBackground: Systemic lupus erythematosus (SLE) is an autoimmune disease which involves multiple organs, including peripheral nervous system.Case presentation: We describe a 12-year-old boy with progressively worsening neurological symptoms as first manifestation. Legs pain, loss of balance, and lower extremity weakness were the reason for his admission in neurologic ward. The patient was started on intravenous immunoglobulin therapy due to the possibility of Guillain–Barre syndrome and acute inflammatory demyelinating polyneuropathy (AIDP). However, there was no appropriate response and he developed recurrent attacks of polyneuropathy again with diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Then, he received intravenous pulse of methylprednisolone for 5 consecutive days followed by oral prednisolone for 3 months. One month after withdrawal of corticosteroid he admitted again with the same manifestations. Rheumatologic workup revealed the presence of leukopenia, hemolytic anemia, hematuria, proteinuria, positive antinuclear antibodies, and ds-DNA antibodies. On the basis of the American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria for SLE, the patient had underlying diagnosis of SLE. Eventually, he was treated by the pulse of methylprednisolone and cyclophosphamide, and oral hydroxychloroquine and prednisolone. His neurological and physical symptoms improved and complete neurological recovery occurred several months later.Conclusion: SLE and AIDP/CIDP are different entities, but ADP/CIDP can be part of the neurologic manifestations of the SLE. Although the association between AIDP/CIDP and SLE is very rare especially as a first manifestation of SLE, it should be early recognized for rapid appropriate treatment.Keywords: Guillain–Barre syndrome, chronic inflammatory demyelinating polyneuropathy, systemic lupus erythematosus, nerve disorders
format article
author Javadi Parvaneh V
Jari M
Qhasemi S
Nasehi MM
Rahmani K
Shiari R
author_facet Javadi Parvaneh V
Jari M
Qhasemi S
Nasehi MM
Rahmani K
Shiari R
author_sort Javadi Parvaneh V
title Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
title_short Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
title_full Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
title_fullStr Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
title_full_unstemmed Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
title_sort guillain–barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/2596f2d1d2c047a0aa3f6f7296aab88a
work_keys_str_mv AT javadiparvanehv guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
AT jarim guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
AT qhasemis guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
AT nasehimm guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
AT rahmanik guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
AT shiarir guillainndashbarresyndromeasthefirstmanifestationofjuvenilesystemiclupuserythematosusacasereport
_version_ 1718401719308648448